A Double Blind, Randomized, Placebo-Controlled, Third-Party Open, Modified Cross-Over Study To Examine The Acute Effect Of PF-04427429 On Capsaicin Flare Response In Healthy Volunteers Using EMLA Cream As Positive Control.

Trial Profile

A Double Blind, Randomized, Placebo-Controlled, Third-Party Open, Modified Cross-Over Study To Examine The Acute Effect Of PF-04427429 On Capsaicin Flare Response In Healthy Volunteers Using EMLA Cream As Positive Control.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Mar 2015

At a glance

  • Drugs Fremanezumab (Primary) ; Lidocaine/prilocaine
  • Indications Migraine; Pain
  • Focus Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 20 Dec 2011 Actual patient number is 12 as reported by ClinicalTrials.gov.
    • 20 Dec 2011 Actual end date Oct 2011 added as reported by ClinicalTrials.gov.
    • 20 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top